RPM for Oncology: ROI & Adoption

Remote patient monitoring (RPM) is a key component of digital health, especially in the field of oncology. Its applications in improving patient outcomes, reducing healthcare costs, and enhancing clinical trials are well-documented and growing. But how can the pharmaceutical industry engage with this evolving field to deliver substantive value to end users?

• How do Pharma define ROI in remote monitoring space?

• What business and go-to-market models drive the adoption of RPM tools in oncology, contributing to a positive ROI?

• What key indicators demonstrate the impact of RPM on oncology care efficiency and financial outcomes, and how are these indicators measured?

• How can barriers to implementing RPM in oncology be overcome for widespread adoption and positive ROI, and what proven strategies exist for addressing these challenges?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.